Cargando…
The Inhibition of Evolocumab on Non-Infarct-Related Artery Disease in Patients with ST-Elevation Myocardial Infarction
PURPOSE: The effects of combing evolocumab and statin on the clinical outcome and physiological function of coronary arteries in STEMI patients with non-infarct-related artery (NIRA) disease are still unclear. METHODS: A total of 355 STEMI patients with NIRA were enrolled in this study, who underwen...
Autores principales: | Zhao, Qi, Sun, Siyuan, Zhou, Fanghui, Yue, Jingkun, Luo, Xing, Qu, Xiufen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319277/ https://www.ncbi.nlm.nih.gov/pubmed/37408846 http://dx.doi.org/10.2147/IJGM.S417481 |
Ejemplares similares
-
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013) -
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020) -
Coronary Artery Aneurysm Presenting as Non-ST Elevation Myocardial Infarction
por: Sundhu, Murtaza, et al.
Publicado: (2017) -
An emergency ECG sign of ST elevation myocardial infarction
por: Qu, Baoze, et al.
Publicado: (2019) -
Are patients with non-ST elevation myocardial infarction undertreated?
por: Rasoul, Saman, et al.
Publicado: (2007)